High-dose chemotherapy in small-cell lung cancer

Anticancer Research

Volumn 22, Issue 6 B, 2002, Pages 3465-3472

  Pasini, F ^a   Durante, E ^a   De Manzoni, D ^a   Rosti, G ^b   Pelosi, G ^c,d  

^a UNIVERSITY OF VERONA   (Italy)

^b Ospedale di Ravenna   (Italy)

^c EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^d Divisione di Anatomia Patologica   (Italy)

Author keywords

Autologous bone marrow transplantation; High dose chemotherapy; Peripheral blood progenitor cells; Small Cell lung cancer

Indexed keywords

CARBOPLATIN; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; HEMOPOIETIC GROWTH FACTOR; IFOSFAMIDE; LOMUSTINE; MELPHALAN; METHOTREXATE; PACLITAXEL;

ASTHENIA; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG FATALITY; DRUG MEGADOSE; HUMAN; INFECTION; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; PROBABILITY; RANDOMIZED CONTROLLED TRIAL; REVIEW; STEM CELL;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW TRANSPLANTATION; CARCINOMA, NON-SMALL-CELL LUNG; CLINICAL TRIALS; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LUNG NEOPLASMS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION;

EID: 0036875583     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. Souhami RL, Harper PG, Linch D et al: High-dose cyclophosphamide with autologous marrow transplantation as initial treatment of small cell carcinoma of the bronchus. Cancer Chemother Pharmacol 8: 31-34, 1982.
2. Souhami RI, Harper PG and Linch D et al: High-dose cyclophosphamide with autologous marrow transplantation for small cell carcinoma of the bronchus. Cancer Chemother Pharmacol 10: 205-207, 1983.
3. Souhami RL, Finn G, Gregory WM et al: High-dose cyclophosphamide in small-cell carcinoma of the lung. J Clin Oncol 3: 958-963, 1985.
4. Souhami RL, Hajichristou RT, Miles DW et al: Intensive chemotherapy with autologous bone marrow transplantation for small-cell lung cancer. Cancer Chemother Pharmacol 24: 321-325, 1989.
5. Gregory WM, Birkhead BG and Souhami RL: A mathematical model of drug resistance applied to treatment for small-cell lung cancer. J Clin Oncol 6: 457-461, 1988.
6. Farha P, Spitzer G, Valdivieso M et al: High-dose chemotherapy and autologous bone marrow transplantation for the treatment of small cell lung carcinoma. Cancer 52: 1351-1355, 1983.
7. Littlewood TJ, Bentley DP and Smith AP: High-dose etoposide with autologous bone marrow transplantation as initial treatment of small cell lung cancer - a negative report. Eur J Respir Dis 68: 370-374, 1986.
8. Leyvraz S, Ketterer N, Perey L et al: Intensification of chemotherapy for the treatment of solid tumours: feasibility of a 3-fold increase in dose intensity with peripheral blood progenitor cells and granulocyte colony-stimulating factor. Br J Cancer 72: 178-182, 1995.
9. Van De Velde H, Bosquée L, Weynants P, Canon JI, Rosier JF and Humbler Y: Moderate dose-escalation of combination chemotherapy with concomitant thoracic radiotherapy in limited disease small cell lung cancer: prolonged intrathoracic tumour control and high central nervous sytem relapse rate. Ann Oncol 10: 1051-1057, 1999.
10. Leyvraz S, Perey L, Rosti G et al: Multiple courses of high-dose ifosfamide, carboplatin, and etoposide with peripheral-blood progenitor cells and filgrastim for small cell lung cancer: a feasibility study by the European Group for Blood and Marrow Transplantation. J Clin Oncol 17: 3531-3539, 1999.
11. Klastersky J, Nicaise C, Longeval E, Stryckmans P and the EORTC Lung Cancer Working Party: Cisplatin, adriamycin, and etoposide (CAV) for remission induction of small-cell bronchogenic carcinoma. Cancer 50: 652-658, 1982.
12. Stewart P, Buckner CD, Thomas ED et al: Intensive chemoradiotherapy with autologous marrow transplantation for small cell carcinoma of the lung. Cancer Treat Rep 67: 1055-1059, 1983.
13. Stahel RA, Takvorian RW, Skarin AT and Canellos GP: Autologous bone marrow transplantation following high-dose chemotherapy with cyclophosphamide, BCNU and VP-16 in small cell carcinoma of the lung and a review of current literature. Eur J Cancer Clin Oncol 20(10): 1233-1238, 1994.
14. 2) with or without autologous bone marrow rescue after conventional chemotherapy in the treatment of patients with small cell lung cancer. Cancer Treatment Reviews 10 (Suppl A), 79-81, 1983.
15. Smith IE, Evans BD, Harland SJ et al: High-dose cyclophosphamide with autologous bone marrow rescue after conventional chemotherapy in the treatment of small cell lung carcinoma. Cancer Chemother Pharmacol 14: 120-124, 1985.
16. Cunningham D, Banham SW, Hutcheon AH et al: High-dose cyclophosphamide and VP 16 as late dosage intensification therapy for small cell carcinoma of lung. Cancer Chemother Pharmacol 15: 303-306, 1985.
17. Sculier JP, Klastersky J, Stryckmans P and the EORTC Lung Cancer Working Party (Belgium): Late intensification in small-cell lung cancer: a phase I study of high doses of cyclophosphamide and etoposide with autologous bone marrow transplantation. J Clin Oncol 3: 184-191, 1985.
18. Ihde DC, Deisseroth AB, Lichter AS et al: Late intensive combined modality therapy followed by autologous bone marrow infusion in extensive-stage small-cell lung cancer. J Clin Oncol 4: 1443-1454, 1986.
19. Spitzer G, Farha P, Valdivieso M et al: High-dose intensification therapy with autologous bone marrow support for limited small-cell bronchogenic carcinoma. J Clin Oncol 4: 4-13, 1986.
20. Spitzer G, Spencer V and Dunphy F: High-dose chemotherapy with autologous bone marrow support for lung cancer. In: High-dose Cancer Chemotherapy, Pharmacology, Hemopoietins, Stem Cells. (Armitage JO, Antman KH, eds). Baltimore, Williams & Williams, 1992, pp 719-728.
21. Pico JL, Baume D, Ostronoff M et al: Chimiotherapie a houtes doses suivie d' autogreffe de moelle osseuse dans le traitement du cancer bronchique a petites cellules. Bull Cancer 74: 587-595, 1987.
22. Humblet Y, Symann M, Bosly A et al: Late intensification chemotherapy with autologous bone marrow transplantation in selected small-cell carcinoma of the lung: a randomized study. J Clin Oncol 5: 1864-1873, 1987.
23. Wilson C, Pickering D Stewart S et al: High-dose cyclophosphamide with autologous bone marrow rescue in small cell lung cancer. In Vivo 2: 331-334, 1988.
24. Marangolo M, Rosti G, Amadori D et al: High-dose etoposide and autologous bone marrow transplantation as intensification treatment in small cell lung cancer: a pilot study. Bone Marrow Transpl 4: 405-408, 1989.
25. Lange A, Kolodziej J, Tomeczko J et al: Aggressive chemotherapy with autologous bone marrow transplantation in small cell lung carcinoma. Arch Immunol Ther Exp (Warsz) 39: 431-439, 1991.
26. rd et al: Intensive combined modality therapy for limited-stage small-cell lung cancer. J Natl Cancer Inst 85: 559-566, 1993.
27. Elias AD: Hemotopoietic stem cell transplantation for small cell lung cancer. Chest 116 (3 Suppl): 531S-538S, 1999.
28. Elias AD, Ibrahim J, Skarin AT et al: Dose-intensive therapy for limited-stage small-cell lung cancer: long-term outcome. J Clin Oncol 17: 1175-1184, 1999.
29. Jennis A, Levitan N, Pecora AL, Isaacs R and Lazarus H: Sequential high dose chemotherapy (HDC) with filgrastim/peripheral stem cell support (PSCS) in extensive stage small cell lung cancer (SCLS). Proceedings American Society Clinical Oncology 15: abstr 1021, 1996.
30. Fetscher S, Brugger W, Engelhardt R et al: Dose intense therapy with etoposide, ifostamide, cisplatin and epirubicin (VIP-E) in 100 consecutive patients with limited-and extensive-disease small-cell lung cancer. Ann Oncol 8: 49-56, 1997.
31. Bessho A, Ueoka H, Kiura K et al: High-dose ifosfamide, carboplatin and etoposide with autologous peripheral blood progenitor cell transplantation for small-cell lung cancer. Anticancer Res 19: 693-698, 1999.
32. Lazarus HM and Elias AD: Autologous bone marrow and peripheral blood progenitor cell transplants in small cell lung cancer. Bone Marrow Transpl 17: 1-3, 1996.
33. Pignon JP, Arriagada R, Idhe DC et al: A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med 327: 1616-1624, 1992.
34. Coiffier B, Philip T, Bumett AK and Symann ML: Consensus conference on intensive chemotherapy plus hematopoietic stem-cell transplantation in malignancies: Lyon, France, June 4-6, 1993. J Clin Oncol 12: 226-231, 1994.
35. Choi NC, Hemdon JE 2nd, Rosenman H et al: Phase I study to determine the maximum-tolerated dose of radiation in standard daily and hyperfractionated-accelerated twice-daily radiation schedules with concurrent chemotherapy for limited-stage small-cell lung cancer. J Clin Oncol 16: 3528-3536, 1998.
36. Turrisi AT erd, Kim K, Blum R et al: Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. N Eng J Med 28; 340: 265-271, 1999.
37. Arriagada R, Le Chevalier T, Borie F et al: Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. J Natl Cancer Inst 87: 183-190, 1995.
38. Gregor A, Cull A, Stephens RJ et al: Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: results of a multicentre randomised trial. Eur J Cancer 11: 1752-1758, 1997.
39. Auperin A, Arriagada R, Pignon JP et al: Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. N Engl J Med 12; 341: 476-484, 1999.
40. Pasini F, Cetto GL and Pelosi G: Does bone marrow involvement affect prognosis in small-cell lung cancer? Ann Oncol 9: 247-250, 1998.
41. Brugger W, Bross K, Glatt, Weber F, Mertelsmann R and Kanz L: Mobilisation of tumour cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors. Blood 83: 636-640, 1994.
42. Pelosi G, Pasini F, Ottensmeier C et al: Immunocytochemical assessment of bone marrow aspirates for monitoring response to chemotherapy in small-cell lung cancer patients. Br J Cancer 81: 1213-1221, 1999.
43. Goldman JM, Schmitz N, Niethammer D and Gratwohl A: Allogeneic and autolofous transplantation for hematologic diseases, solid tumors and immune diseases: current practice in Europe in 1998. Bone Marrow Transplant 21: 1-7, 1998.
44. MacNeil M and Eisenhauer EA: High-dose chemotherapy: is it standard management for any common solid tumour? Ann Oncol 10: 1145-1161, 1999.
45. Rosti G, Ferrante P, Ledermann J et al: High-dose chemotherapy for solid tumors: results of the EBMT. Critical Reviews in Oncology/Hematology 41: 129-140, 2002.